Rick Wagner, Ph.D.
Interim President and COO
Rick Wagner, Ph.D., is the founder of X-Chem, Inc., X-Rx, Inc., and X-BODY Biosciences. Wagner currently serves as interim president and chief operating officer of X-Rx, and chief executive officer and president of X-Chem .
Jeffrey Troderman, CPA, MBA
Chief Financial Officer
Jeff Troderman has more than 25 years of financial management and consulting experience culminating in his current position as Chief Financial Officer of X-Rx, Inc. Prior to joining X-Rx, Jeff spent nearly 15 years as a principal at two regional consulting firms where he served as interim CFO for a broad client base, including many life science companies.
Director of Project Management
Julie Robey, Director of Project Management, has more than 20 years of data management, clinical management and project management experience across multiple indications in Phase I-IV studies.